Neil Johnson

Research activity per year

Filter

2023
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
Australian Ovarian Cancer Study, Nesic, K., Krais, J. J., Wang, Y., Vandenberg, C. J., Patel, P., Cai, K. Q., Kwan, T., Lieschke, E., Ho, G. Y., Barker, H. E., Bedo, J., Casadei, S., Farrell, A., Radke, M., Shield-Artin, K., Penington, J. S., Geissler, F., Kyran, E. & Betsch, R. & 18 others, Xu, L., Zhang, F., Dobrovic, A., Olesen, I., Kristeleit, R., Oza, A., McNeish, I., Ratnayake, G., Traficante, N., DeFazio, A., Bowtell, D. D. L., Harding, T. C., Lin, K., Swisher, E. M., Kondrashova, O., Scott, C. L., Johnson, N. & Wakefield, M. J., Aug 28 2023, 1 ed., p. 158, 1 p. (medRxiv : the preprint server for health sciences).
Research output: Working paper › Preprint

Open Access
6 Scopus citations
FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphatase
Wasserman, J. S., Faezov, B., Patel, K. R., Kurimchak, A. N., Palacio, S. M., Fowle, H., McEwan, B. C., Xu, Q., Zhao, Z., Cressey, L., Johnson, N., Duncan, J. S., Kettenbach, A. N., Dunbrack, R. L. & Grana, X., 2023, (bioRxiv : the preprint server for biology).
Research output: Working paper › Preprint

Neil Johnson, PhD